G. Comella

1.7k total citations
70 papers, 1.2k citations indexed

About

G. Comella is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, G. Comella has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in G. Comella's work include Cancer Treatment and Pharmacology (32 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Treatments and Mutations (17 papers). G. Comella is often cited by papers focused on Cancer Treatment and Pharmacology (32 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Treatments and Mutations (17 papers). G. Comella collaborates with scholars based in Italy, United States and Malaysia. G. Comella's co-authors include P. Comella, G. Frasci, Francesco Caponigro, Patrick Schöffski, G. Greim, J. Wanders, Aarón Sulkes, M. Borner, Godefridus J. Peters and Ronald de Wit and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

G. Comella

69 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. Comella Italy	21	978	435	235	209	190	70	1.2k
Epaminontas Samantas Greece	18	857 0.9×	621 1.4×	248 1.1×	232 1.1×	181 1.0×	62	1.2k
S. Palmeri Italy	17	584 0.6×	228 0.5×	121 0.5×	127 0.6×	116 0.6×	78	821
Rita Lionetto Italy	20	962 1.0×	320 0.7×	133 0.6×	295 1.4×	295 1.6×	53	1.4k
Lloyd K. Everson United States	16	978 1.0×	382 0.9×	163 0.7×	236 1.1×	195 1.0×	30	1.5k
Sandra J. Casak United States	18	455 0.5×	215 0.5×	171 0.7×	189 0.9×	107 0.6×	32	1.0k
B. Mirtsching United States	12	1.1k 1.2×	459 1.1×	182 0.8×	131 0.6×	288 1.5×	27	1.3k
Giuseppe Comella Italy	16	817 0.8×	642 1.5×	163 0.7×	88 0.4×	112 0.6×	42	1.1k
Federica Cuppone Italy	20	1.1k 1.2×	604 1.4×	199 0.8×	111 0.5×	388 2.0×	50	1.5k
Natsuko Okita Japan	20	855 0.9×	518 1.2×	278 1.2×	271 1.3×	135 0.7×	110	1.3k
A. Antón Spain	18	1.3k 1.3×	695 1.6×	178 0.8×	256 1.2×	492 2.6×	103	1.7k

Countries citing papers authored by G. Comella

Since Specialization

Citations

This map shows the geographic impact of G. Comella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Comella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Comella more than expected).

Fields of papers citing papers by G. Comella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Comella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Comella. The network helps show where G. Comella may publish in the future.

Co-authorship network of co-authors of G. Comella

This figure shows the co-authorship network connecting the top 25 collaborators of G. Comella. A scholar is included among the top collaborators of G. Comella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Comella. G. Comella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Comella, P., Massimo Rinaldo, Giovanni Iodice, et al.. (2009). Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer. Annals of Oncology. 20(7). 1185–1192. 71 indexed citations

Palmeri, S., Stefano Spada, Gianfranco Filippelli, et al.. (2005). Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study. Oncology. 68(4-6). 438–445. 16 indexed citations

Frasci, G., P. Comella, R. Thomas, et al.. (2005). A two-month cisplatin-epirubicin-paclitaxel (PET) weekly administration is highly effective in large operable breast cancer. Final analysis of a SICOG phase II study. Journal of Clinical Oncology. 23(16_suppl). 566–566. 4 indexed citations

D’Aiuto, Giuseppe, P. Comella, R. Thomas, et al.. (2005). A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study. Annals of Oncology. 16(8). 1268–1275. 9 indexed citations

Cantore, Maurizio, G. Fiorentini, Gabriele Luppi, et al.. (2004). Ceravolo. Journal of Chemotherapy. 16(6). 589–594. 21 indexed citations

Colombino, Maria, Antonio Cossu, Antonella Manca, et al.. (2003). Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases. Annals of Oncology. 14(10). 1530–1536. 14 indexed citations

Comella, P., Rossana Casaretti, Vincenzo De Rosa, et al.. (2002). Oxaliplatin plus irinotecan and leucovorin-modulated5-fluorouracil triplet regimen every other week:a dose-finding study in patients with advanced gastrointestinal malignancies. Annals of Oncology. 13(12). 1874–1881. 20 indexed citations

Cascinu, Stefano, Francesco Graziano, Sandro Barni, et al.. (2001). A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. British Journal of Cancer. 84(4). 470–474. 40 indexed citations

Frasci, G., G.P. Nicolella, P. Comella, et al.. (2001). A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study. British Journal of Cancer. 84(9). 1166–1171. 24 indexed citations

10.

Ardizzoni, Andrea, Giovanna Antonelli, Sante Basso Ricci, et al.. (2000). Ambamustine in the Second-Line Treatment of Patients With Small-Cell Lung Cancer. American Journal of Clinical Oncology. 23(1). 22–25. 7 indexed citations

11.

Cascinu, Stefano, L. Frontini, G. Comella, et al.. (1999). Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). British Journal of Cancer. 79(3-4). 491–494. 4 indexed citations

12.

Frasci, G., P. Comella, N. Panza, et al.. (1998). Carboplatin–oral etoposide personalised dosing in elderly non-small cell lung cancer patients. European Journal of Cancer. 34(11). 1710–1714. 20 indexed citations

13.

Labianca, Roberto, Stefano Cascinu, L. Frontini, et al.. (1997). High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study. Annals of Oncology. 8(2). 169–174. 20 indexed citations

14.

Comella, P., Antonio Daponte, Rossana Casaretti, et al.. (1997). Fotemustine and dacarbazine plus recombinant interferon alpha2a in the treatment of advanced melanoma. European Journal of Cancer. 33(8). 1326–1329. 10 indexed citations

15.

Frasci, G., P. Comella, Cesare Guida, et al.. (1997). Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.. Journal of Clinical Oncology. 15(4). 1409–1417. 23 indexed citations

16.

Comella, P., G. Frasci, N. Panza, et al.. (1996). Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. British Journal of Cancer. 74(11). 1805–1811. 35 indexed citations

17.

Baldini, Editta, Carmelo Tibaldi, E. Pfanner, et al.. (1996). Phase II Study of Oral Doxifluridine in Elderly Patients with Advanced Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 19(6). 592–594. 9 indexed citations

18.

Comella, P., Giuseppe Palmieri, Vito Lorusso, et al.. (1996). Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies. European Journal of Cancer. 32(10). 1719–1726. 11 indexed citations

19.

Bajetta, Emilio, Angelo Di Leo, Maria Giulia Zampino, et al.. (1994). Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.. Journal of Clinical Oncology. 12(4). 806–811. 108 indexed citations

20.

Claudio, F, Mario Rotondi, Stefano Bonassi, et al.. (1992). Factors affecting response and survival in advanced head and neck cancers treated with intraarterial chemotherapy. 4(4). 180–187. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact